Cowan Elvia 4
4 · Vaxcyte, Inc. · Filed Nov 8, 2024
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Cowan Elvia
SVP, FINANCE
Transactions
- Award
Performance Stock Option (right to buy)
2024-11-07+11,900→ 11,900 totalExercise: $102.70Exp: 2034-11-06→ Common Stock (11,900 underlying)
Footnotes (1)
- [F1]As part of a company-wide grant to all eligible employees of the Issuer, on November 7, 2024 (the "Grant Date"), the Reporting Person was granted a performance stock option to purchase 11,900 shares of the Issuer's Common Stock at a per share exercise price of $102.70. The option is subject to (1) a service-based vesting condition (vesting as to one-third of the shares on each of the third, fourth and fifth anniversaries of the Grant Date) and (2) a performance-vesting condition (which generally requires that the trading price of the Issuer's Common Stock average, over a one-year period, is at least $154.05 (150% of the Grant Date closing price)).